All of the statements are true about Brugada syndrome, EXCEPT:

A. Transient ST segment elevation in lead V1-V3 is seen

B. Responsible for the sudden and unexpected nocturnal death syndrome

C. Risk of fatal ventricular arrhythmia is more

D. Flecainide can be used to treat

Correct Answer: Flecainide can be used to treat

Description: The major clinical features of Brugada syndrome include, transient, or concealed ST segment elevation in V1 to V3 that typically can be provoked with the sodium channel-blocking drugs flecainide, and procainamide and a risk of polymorphic ventricular arrhythmias. Ref: Harrisons Principles of Internal Medicine, 18th Edition, Page 1898.

Category: Medicine

Share:

← Previous MCQ

Next MCQ →

Get More

Subject Mock Tests

Practice with over 200,000 questions from various medical subjects and improve your knowledge.

Attempt a mock test now

Mock Exam

Take an exam with 100 random questions selected from all subjects to test your knowledge.

Coming Soon

Get More

Subject Mock Tests

Try practicing mock tests with over 200,000 questions from various medical subjects.

Attempt a mock test now

Mock Exam

Attempt an exam of 100 questions randomly chosen from all subjects.

Coming Soon